Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma

NCT04699604 is registered in ClinicalTrials.gov with Bridgette Jones as lead sponsor.

NCT NCT04699604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04699604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma
Lead sponsor
Bridgette Jones
Phase
Phase 3
Overall status
Completed
Start date
April 28, 2021
Completion date
April 26, 2026
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma